Conservative Care for Pelvic Pain (C2P2) in Women Service Members

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-50
SponsorBaylor University

About this trial

This study will test the effectiveness of emerging conservative interventions for treatment of chronic pelvic pain (CPP) that can be performed without intravaginal specialization. Participants with CPP will be randomly assigned to one of three groups. The first group will receive treatment based on what they normally would receive, including medications, education, and exercise (Usual Care Group). The second group will receive contemporary non-vaginal treatment including manual therapy, dry needling, and specific breathing training (Emerging Field-expedient Care Group). The third group will receive intravaginal treatment by a pelvic health specialist (Gold-standard Intravaginal Specialist Care Group). Participants will be asked about their pain and symptoms and have measurements taken of their pelvic and back muscles after 1, 3, 6, and 12 months. In addition to seeing which treatments work best, clinical decision tools (using medical and trauma history along with clinical examination) will be developed to identify women with CPP likely to respond favorably to non-vaginal conservative interventions. This study will help determine the best non-vaginal treatment strategies for women with CPP and help clinicians quickly determine which patients are likely to benefit from treatment by non-pelvic health physical therapists (e.g., in theater), vs. patients who should be referred for pelvic health specialty care.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

Sign that pelvic pain may be due to other serious medical issue (recent history of abdominal pelvic surgery, current infection, disrupted tissue integrity, neoplasm, or history of radiation to the pelvic floor tissue or the tissues being measured for stiffness).

Chronic debilitating medical conditions (e.g., fibromyalgia, lupus, complex regional pain syndrome, multiple sclerosis or other progressive neurologic condition).

Currently pregnant or pregnancy in the last 6 months.

Body mass index over 33 (Waco participants only due to limitation of the instrumentation).

Trial design

Design model

Parallel

Treatments tested in this trial

  • Pain Neuroscience Education

    Other intervention

    Participants will watch and discuss a short (5-minute) standardized pain neuroscience education video with their treating provider. The video explains and illustrates how chronic pain is different than acute pain in that it concerns nervous system hypersensitivity more than local tissue damage. Pain neuroscience education principles from the video will then be used to throughout all interventions to coach the participants through graded exposure of activities that may have previously been painful or provoked anxiety.

  • Lumbopelvic and Hip Therapeutic Exercise

    Other intervention

    These motor control exercises will focus on proprioception, coordination, and sensorimotor control training and include progressive exercises that focus on transversus abdominis, lumbar multifidus, diaphragmatic, pelvic floor muscles, and deep hip stabilizers. Exercises will progress from more stabilized (e.g., pelvic tilt, cat and cow) to less stabilized and more dynamic and functional (e.g., forward bending, eccentric squat) to mimic the demands of work duty. Exercise will be trained and progressed during the clinical visits and be performed daily at home.

  • Extrapelvic Manual Therapy

    Other intervention

    Thrust and non-thrust manual therapy will be applied to the lumbar facet, sacroiliac, and hip joints based upon the clinical exam in a semi-standardized manner

  • Extrapelvic Dry Needling

    Other intervention

    Dry needling treatment to muscles of the lumbopelvic and upper thigh regions in a semi-standardized manner based upon a palpatory examination. The palpatory examination will include the erector spinae, lumbar multifidi, gluteus medius/minimus, piriformis, illiacus, and hip adductor muscles.

  • Deep Paced Diaphragmatic Breathing Training

    Other intervention

    The breathing intervention will start with education describing the link between the diaphragm and the pelvic floor to include awareness of any breath holding patterns and finding positions that facilitate expansion of the ribs, abdominals, and pelvic floor muscles with inhalation. Then progressive training will be given to encourage deep breathing at a pace of approximately 6 breaths per minute.

  • Chronic Pelvic Pain Education

    Other intervention

    During the first visit, participants will receive and briefly discuss the 2023 standardized patient educational handout created by the International Pelvic Pain Society with their treating provider. The educational handout describes chronic pelvic pain etiology, typical symptoms, examination, and treatments.

  • Intravaginal and intrarectal pelvic floor physical therapy

    Other intervention

    Superficial vulvar, perineal and intravaginal manual therapy and biofeedback utilizing commonly used techniques in previous research selected based on identified impairments from the pelvic floor examination will be performed.

Treatment groups

300 Participants
are divided into 3 treatment groups
Group A: Usual CareActive comparator 2 interventions
Group B: Emerging Field-expedient CareExperimental treatment 6 interventions
Group C: Gold-standard Intravaginal Specialist CareActive comparator 5 interventions

Trial outcomes

Primary outcomes

1

The Pelvic Floor Distress Inventory (PFDI-20)

The Pelvic Floor Distress Inventory (PFDI-20) is a 20-item questionnaire that assesses the frequency and severity of pelvic floor symptoms. It consists of 3 subscales: the pelvic floor distress inventory 6 (POPDI-6), the colorectal anal distress inventory 8 (CRADI-8), and the urinary distress inventory 6 (UDI-6). Each question is rated on a scale of 0-4 with 0 representing "no symptoms," and 4 representing "quite a bit." Higher scores represent more bothersome symptoms.

Time frame
1 week and 1, 3, 6, and 12 months
2

The Genitourinary Pain Index (GUPI)

The Genitourinary Pain Index (GUPI) is 9-item questionnaire that assesses presence, location, frequency, quality and quantity of genitourinary pain in both men and women.

Time frame
1 week and 1, 3, 6, and 12 months

Secondary outcomes

1

Numeric pain rating scale (NPRS)

Participants will rate their current pain on a scale of 0-10 with zero being no pain at all and 10 being the worst pain imaginable. Subjects will also rate their worst pain within the past week and their pain at its best within the last week, to gain an assessment of variability and intensity of pain.

Time frame
1 week and 1, 3, 6, and 12 months
2

Pelvic Floor Muscle Tone

On a subset of 150 participants, pelvic floor muscle tone will be estimated from shear wave elastography ultrasound (US).

Time frame
1 week and 1, 3, 6, and 12 months
3

Superficial Lumbopelvic Muscle Tone

On a subset of 150 participants, resting tone of several lumbopelvic muscles will be measures using a MyotonPRO device.

Time frame
1 week and 1, 3, 6, and 12 months
4

Pelvic Floor Pain Sensitivity

On a subset of 150 participants, pelvic floor pain sensitivity will be assessed using pain algometry.

Time frame
1 week and 1, 3, 6, and 12 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Baylor University

Lead sponsor

Congressionally Directed Medical Research Programs

Collaborator

This trial is not recruiting at the moment. You can still explore other options: